Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Seeks to Ensure Accountability and Deliver Organized, Accurate and Actionable Information for Legal Staff Worldwide HARTFORD, Conn., Feb. 24 /PRNewswire/ -- CT TyMetrix, part of CT, a Wolters...
Voalte(R) partners with Emergin to integrate Apple devices at the point of care BOCA RATON, Fla., Feb. 23, 2010 /PRNewswire-FirstCall/ -- Emergin, a Philips Healthcare company, announced today...
Use of new Philips VISICU program improves management of severe sepsis MIAMI, Jan. 11, 2010 /PRNewswire-FirstCall/ -- Severe sepsis is a leading cause of death in intensive care units. According...
High-performance architectural floodlights illuminate the prominent building just in time for the holiday season BURLINGTON, Mass., Dec. 15 /PRNewswire/ -- Philips Electronics today added...
CHICAGO, Nov. 29 /PRNewswire/ -- Royal Philips Electronics (NYSE:PHGNYSE: AEX:NYSE:PHI) today announced its response to an industry need by showing its portfolio of products designed to manage...
Leading cancer center delivers first clinical VMAT treatment in the U.S. planned with innovative SmartArc TAMPA, Fla., Nov. 13 /PRNewswire/ -- Royal Philips Electronics (NYSE:PHGNYSE:...
Agreement Includes Commercial Relationship, License by LSG, and Investment by Philips NEW YORK, Aug. 31 /PRNewswire-FirstCall/ -- Lighting Science Group Corporation ("LSG") and Royal Philips...
SAN DIEGO, July 24 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) ("Cardium") today announced that it has completed the asset sale of Cardium's InnerCool Therapies business...
AMSTERDAM and SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- Royal Philips (AEX:PHIAEX:NYSE:AEX:PHG) announced today that it has reached an agreement to acquire the assets of InnerCool Therapies...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
